<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68088">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02219464</url>
  </required_header>
  <id_info>
    <org_study_id>130627</org_study_id>
    <nct_id>NCT02219464</nct_id>
  </id_info>
  <brief_title>Nasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery Patients</brief_title>
  <official_title>Nasopharyngeal Versus Nasal Cannula Oxygen Supplementation in Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to conduct a randomized, controlled trial comparing nasopharyngeal
      oxygen supplementation to traditional nasal cannula in patients undergoing oral surgery
      under moderate sedation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of oxygen saturations below 92%</measure>
    <time_frame>During surgical procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of needed airway assistance interventions</measure>
    <time_frame>During surgical procedure</time_frame>
    <description>(jaw lift, tongue retraction, oral airway placement, mask ventilation, increase in oxygen flow rate, ect.).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-tidal carbon dioxide</measure>
    <time_frame>During surgical procedure</time_frame>
    <description>End-tidal carbon dioxide tracings will be compared between the two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Oxygen Administration During Deep Sedation</condition>
  <arm_group>
    <arm_group_label>Nasopharyngeal catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive oxygen supplementation through the use of a Nasopharyngeal catheter. Sedation will be standardized to ensure consistency between groups.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal Cannula</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will receive oxygen supplementation through the use of a traditional nasal cannula. Sedation will be standardized to ensure consistency between groups.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasopharyngeal catheter</intervention_name>
    <arm_group_label>Nasopharyngeal catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal Cannula</intervention_name>
    <arm_group_label>Nasal Cannula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oxygen Supplementation</intervention_name>
    <description>Initially set at 3 liters/minute</description>
    <arm_group_label>Nasopharyngeal catheter</arm_group_label>
    <arm_group_label>Nasal Cannula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sedation</intervention_name>
    <description>Midazolam 2mg IV, Fentanyl 100mcg IV, Propofol 100 mcg/kg/min. Additional doses of propofol at the discretion of the attending anesthesiologist.</description>
    <arm_group_label>Nasopharyngeal catheter</arm_group_label>
    <arm_group_label>Nasal Cannula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients greater than 16 years of age

          -  Patients who present for oral surgery or esophagoduodenography and colonoscopy

          -  Patients who undergo intravenous sedation

        Exclusion Criteria:

          -  Patients who require endotracheal intubation

          -  ASA class 4 or higher

          -  Existing esophageal disease such as a perforation or varices
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bret Alvis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 3, 2016</lastchanged_date>
  <firstreceived_date>August 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Bret Alvis</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>nasopharyngeal catheter</keyword>
  <keyword>nasal cannula</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
